Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
22%
Ph not_applicable
7
78%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting3
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (22.2%)
N/A7 (77.8%)

Trials by Status

withdrawn111%
recruiting333%
not_yet_recruiting111%
completed444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9